Scientific publications

Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

Bosch-Barrera J., Espinós J. [SP], Gómez-Ibáñez A., Gállego Pérez-Larraya J. [SP], Iriarte J.
Department of Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.

Magazine: Clinical and Translational Oncology

Date: Nov 1, 2009

Neurology [SP] Neurophysiology [SP] Medical Oncology Breast Cancer Area

Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer.

We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.

CITATION  Clin Transl Oncol. 2009 Nov;11(11):765-7

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra